About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Women may be Stopping IVF Treatment Prematurely: Celmatix Study

by Bidita Debnath on October 21, 2013 at 11:10 PM
 Women may be Stopping IVF Treatment Prematurely: Celmatix Study

Celmatix is a biotechnology company focused on helpingphysicians guide patients to treatments that maximize their personal reproductive potential.

It announced six research presentations at the annual meeting of the American Society for Reproductive Medicine (ASRM), being held October 12­17 in Boston.

Advertisement

Among the data presented was a new study suggesting that up to 25 percent of patients may be discontinuing assisted reproductive therapies such as in vitro fertilization (IVF) early, while they still have a good chance of having a baby. The clinical study, which was performed on a dataset of over 6,000 patients from study co­authors Reproductive Medicine Associates of New York, showed that 68 percent of women conceived within two cycles.

For those who did not conceive in that time frame and chose to discontinue treatment, the data suggested that more than half (60 percent) would have become pregnant if they had proceeded with an additional two treatment cycles. Other Celmatix findings being presented at ASRM include data on genetic markers related to currently unexplained female infertility and IVF success; factors correlated with higher risk of ectopic pregnancy; and an analytical model that predicts the estimated number of cycles needed by a particular couple to achieve live birth using various fertility treatments.
Advertisement

"We are excited to have this opportunity to present our research findings at ASRM, especially our finding that most patients who are initially unsuccessful with fertility treatments still have a significant chance of having a baby," said Piraye Yurttas Beim, PhD, Founder and Chief Executive Officer of Celmatix. "There are so many unanswered questions about why some women struggle with fertility. These questions create difficult decisions for women and their healthcare providers. Our goal is to offer tools and resources that make this process as informed and evidence­based as possible."

The oral abstracts presented by Celmatix were:
  • Patients Discontinue Assisted Reproductive Technology (ART) Too Early: The Results of a Large Multiyear Cohort Study
  • A Novel Role for Genomic Copy Number Variants in Female Infertility
  • Accurate Prediction of the Number of Cycles to Achieve Live Birth

The three poster presentations were:
  • Improved Determination of Ectopic Pregnancy Risks in Patients Undergoing In Vitro Fertilization Using Time­To­Event Models
  • Whole Genome Sequencing for Female Infertility Biomarker Discovery
  • Targeted Resequencing Sheds Light on the Etiology of Unexplained Female Infertility

    Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Research News

Insight into Cellular Stress: Mechanisms Behind mRNA Sequestration Revealed
The discovery deepens our understanding of m6A biology and stress granule formation, with implications for neurodegenerative diseases.
Disrupted Circadian Rhythm Elevates the Risk of Parkinson's Disease
Trouble with sleep and the body's clock may increase your risk for Parkinson's, as per a new study.
A Wake-Up Call for Women — Hot Flashes Could Point to Alzheimer's Risk
New study uncovers a link between nocturnal hot flashes and Alzheimer's risk in menopausal women, suggesting a potential biomarker.
Breakthrough Brain-Centered Approach Reduces Chronic Back Pain
Our discovery revealed that a minority of individuals attributed their chronic pain to their brain's involvement.
New Statement to Protect Athletes' Health Published
Relative Energy Deficiency in Sport syndrome is overlooked by athletes and can be worsened by 'sports culture' due to its perceived short-term performance benefits.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Women may be Stopping IVF Treatment Prematurely: Celmatix Study Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests